Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sauerberg

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|September 1, 1995
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacyclesJ S Ward, L Merritt, D O Calligaro, et al.
Life Sciences|March 9, 1999
Potential role of muscarinic receptors in schizophreniaF P Bymaster, H E Shannon, K Rasmussen, et al.
Life Sciences|January 1, 1997
In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonistH E Shannon, D E Womer, F P Bymaster, et al.
Journal of Medicinal Chemistry|October 23, 1998
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activityP Sauerberg, L Jeppesen, P H Olesen, et al.
Brain Research|June 12, 1998
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effectsF P Bymaster, P A Carter, S C Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Journal of Medicinal Chemistry|February 14, 1997
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndromeC H Mitch, T J Brown, F P Bymaster, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|September 1, 1995
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacyclesJ S Ward, L Merritt, D O Calligaro, et al.
Life Sciences|March 9, 1999
Potential role of muscarinic receptors in schizophreniaF P Bymaster, H E Shannon, K Rasmussen, et al.
Life Sciences|January 1, 1997
In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonistH E Shannon, D E Womer, F P Bymaster, et al.
Journal of Medicinal Chemistry|October 23, 1998
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activityP Sauerberg, L Jeppesen, P H Olesen, et al.
Brain Research|June 12, 1998
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effectsF P Bymaster, P A Carter, S C Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Journal of Medicinal Chemistry|February 14, 1997
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndromeC H Mitch, T J Brown, F P Bymaster, et al.
Pageof 4